Search

Your search keyword '"Gackowski, Daniel"' showing total 182 results

Search Constraints

Start Over You searched for: Author "Gackowski, Daniel" Remove constraint Author: "Gackowski, Daniel" Search Limiters Full Text Remove constraint Search Limiters: Full Text
182 results on '"Gackowski, Daniel"'

Search Results

5. Selective Estrogen Receptor Modulators' (SERMs) Influence on TET3 Expression in Breast Cancer Cell Lines with Distinct Biological Subtypes.

6. Exploring the crop epigenome: a comparison of DNA methylation profiling techniques

7. The urinary excretion of epigenetically modified DNA as a marker of pediatric ALL status and chemotherapy response

8. LINE-1 transcription in round spermatids is associated with accretion of 5-carboxylcytosine in their open reading frames

9. PB1914: UNPRECEDENTED ACCUMULATION OF 5-HYDROXYMETHYLURACIL IN CHRONIC LYMPHOCYTIC LEUKEMIA –POTENTIAL SOURCES AND CLINICAL IMPLICATIONS

10. Context dependent effects of ascorbic acid treatment in TET2 mutant myeloid neoplasia

11. Exploring the crop epigenome: a comparison of DNA methylation profiling techniques

12. Exploring the crop epigenome: a comparison of DNA methylation profiling techniques

15. Unprecedentedly High Level of Intracellular Vitamin C and DNA Epigenetic Marks in Prostate: Relevant for Male Fertility?

16. In vivo evidence of ascorbate involvement in the generation of epigenetic DNA modifications in leukocytes from patients with colorectal carcinoma, benign adenoma and inflammatory bowel disease

17. Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditions—benign adenomas and inflammatory bowel disease

18. Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory study

19. Diagnostic and Prognostic Power of Active DNA Demethylation Pathway Intermediates in Acute Myelogenous Leukemia and Myelodysplastic Syndromes

22. An IDH-independent mechanism of DNA hypermethylation upon VHL inactivation in cancer.

23. Targeted DNA oxidation by LSD1–SMAD2/3 primes TGF-β1/ EMT genes for activation or repression

25. Mass spectrometry reveals the presence of specific set of epigenetic DNA modifications in the Norway spruce genome

28. MOESM1 of In vivo evidence of ascorbate involvement in the generation of epigenetic DNA modifications in leukocytes from patients with colorectal carcinoma, benign adenoma and inflammatory bowel disease

29. Additional file 3: of Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditionsâ benign adenomas and inflammatory bowel disease

30. Additional file 2: of Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditionsâ benign adenomas and inflammatory bowel disease

31. Additional file 1: of Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditionsâ benign adenomas and inflammatory bowel disease

32. TET2 Loss Accelerates Leukemogenesis By Disrupting Mismatch Repair Proteins

33. 5-formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respectively

34. Modulation of TET2 Activity By Ascorbic Acid and Factors Affecting Lysine Acetylation

36. Correction: Profiles of a broad spectrum of epigenetic DNA modifications in normal and malignant human cell lines: Proliferation rate is not the major factor responsible for the 5-hydroxymethyl-2′-deoxycytidine level in cultured cancerous cell lines

37. Profiles of a broad spectrum of epigenetic DNA modifications in normal and malignant human cell lines: Proliferation rate is not the major factor responsible for the 5-hydroxymethyl-2′-deoxycytidine level in cultured cancerous cell lines

40. 8-Oxo-7,8-dihydroguanine and uric acid as efficient predictors of survival in colon cancer patients

41. Systemic oxidoreductive balance in patients without clinical manifestation of atherosclerosis.

45. Establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study

47. Human and methodological sources of variability in the measurement of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine

49. Measurement of DNA oxidation in human cells by chromatographic and enzymic methods

50. Measurement of DNA oxidation in human cells by chromatographic and enzymatic methods

Catalog

Books, media, physical & digital resources